Piper Sandler Companies has strengthened its healthcare investment banking team with the appointment of Jason Arnold as managing director. Based initially in London, Arnold will work with clients around the world, advising life science tools and diagnostics companies on mergers and acquisitions, strategic partnerships, and capital-raising initiatives.
Financial Technology Insights: Metropolitan Commercial Bank Retires ACH Mainframe
The move reflects Piper Sandler’s continued focus on expanding its global healthcare advisory capabilities. Peter Day, global group head of healthcare investment banking, expressed confidence in Arnold’s addition to the team, noting that his deep experience across the tools and diagnostics landscape — particularly in Europe and international markets — will further enhance the firm’s ability to deliver strategic guidance to executives and boards navigating complex decisions.
Financial Technology Insights: Bybit EU Expands Regulated USDC, EURC Programs
Arnold joins Piper Sandler after a 16-year tenure at William Blair, where he served as partner and managing director within its healthcare investment banking group. Over the years, he has built strong relationships across the life sciences ecosystem, advising companies at critical moments of growth and transformation. He began his career at Ernst & Young and holds both a bachelor’s and master’s degree from the University of Colorado, Boulder.
Financial Technology Insights: Paysafe Expands U.S. Agent Recruitment Program
Sharing his enthusiasm about the transition, Arnold highlighted the firm’s deep sector expertise and broad engagement across the healthcare landscape. He emphasized his commitment to helping clients execute sophisticated strategic and capital markets decisions with clarity and confidence, building on Piper Sandler’s established leadership in life science tools and diagnostics.
To share your insights with the FinTech Newsroom, please write to us at sudipto@intentamplify.com